Literature DB >> 19923169

2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Frederick G Kushner, Mary Hand, Sidney C Smith, Spencer B King, Jeffrey L Anderson, Elliott M Antman, Steven R Bailey, Eric R Bates, James C Blankenship, Donald E Casey, Lee A Green, Judith S Hochman, Alice K Jacobs, Harlan M Krumholz, Douglass A Morrison, Joseph P Ornato, David L Pearle, Eric D Peterson, Michael A Sloan, Patrick L Whitlow, David O Williams.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19923169     DOI: 10.1161/CIRCULATIONAHA.109.192663

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  212 in total

1.  Targeting proteases in atherosclerosis: hitting the nail with the hammer.

Authors:  Daniel I Simon; Mukesh K Jain
Journal:  Circulation       Date:  2011-12-06       Impact factor: 29.690

2.  Safety of clopidogrel in older patients: a nonrandomized, parallel-group, controlled, two-centre study.

Authors:  Serkan Cay; Goksel Cagirci; Sinan Aydogdu; Yucel Balbay; Nihat Sen; Orhan Maden; Ahmet D Demir; Ali R Erbay
Journal:  Drugs Aging       Date:  2011-02-01       Impact factor: 3.923

Review 3.  Under-prescribing and non-adherence to medications after coronary bypass surgery in older adults: strategies to improve adherence.

Authors:  David Sengstock; Peter Vaitkevicius; Ahmed Salama; Robert M Mentzer
Journal:  Drugs Aging       Date:  2012-02-01       Impact factor: 3.923

4.  Platelet inhibition and GP IIb/IIIa receptor occupancy by intracoronary versus intravenous bolus administration of abciximab in patients with ST-elevation myocardial infarction.

Authors:  Steffen Desch; Annelie Siegemund; Ute Scholz; Natalie Adam; Ingo Eitel; Suzanne de Waha; Georg Fürnau; Philipp Lurz; Sabrina Wetzel; Gerhard Schuler; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2011-10-21       Impact factor: 5.460

5.  National performance on door-in to door-out time among patients transferred for primary percutaneous coronary intervention.

Authors:  Jeph Herrin; Lauren E Miller; Dima F Turkmani; Wato Nsa; Elizabeth E Drye; Susannah M Bernheim; Shari M Ling; Michael T Rapp; Lein F Han; Dale W Bratzler; Elizabeth H Bradley; Brahmajee K Nallamothu; Henry H Ting; Harlan M Krumholz
Journal:  Arch Intern Med       Date:  2011-11-28

Review 6.  Arterial thrombosis--insidious, unpredictable and deadly.

Authors:  Shaun P Jackson
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

7.  Impact of type of thrombolytic agent on in-hospital outcomes in ST-segment elevation myocardial infarction patients in the Middle East.

Authors:  Ibrahim Al-Zakwani; Amr Ali; Mohammad Zubaid; Prashanth Panduranga; Kadhim Sulaiman; Ahmed Abusham; Wael Almahmeed; Ahmed Al-Motarreb; Jassim Al Suwaidi; Haitham Amin
Journal:  J Thromb Thrombolysis       Date:  2012-04       Impact factor: 2.300

8.  Adverse cardiovascular outcomes associated with concurrent use of clopidogrel or ticlopidine and proton-pump inhibitors in patients undergoing percutaneous coronary intervention.

Authors:  Atsuko Nakayama; Hiroyuki Morita; Jiro Ando; Hideo Fujita; Hiroshi Ohtsu; Ryozo Nagai
Journal:  Heart Vessels       Date:  2012-03-30       Impact factor: 2.037

9.  Sex differences in the treatment and outcome of patients with acute coronary syndrome after percutaneous coronary intervention: a population-based study.

Authors:  Chen-Fang Lin; Li-Jiuan Shen; Fei-Yuan Hsiao; Churn-Shiouh Gau; Fe-Lin Lin Wu
Journal:  J Womens Health (Larchmt)       Date:  2013-11-28       Impact factor: 2.681

10.  'Generic to genetic' transition in cardiovascular and neuropsychiatric drugs: opportunity for personalized medicine.

Authors:  Jorge Duconge; Gualberto Ruaño
Journal:  Pharmacogenomics       Date:  2012-07       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.